Kurepen-XL Tablet is a combination antibiotic formulation containing Amoxycillin 875 mg and Clavulanic Acid 125 mg, designed to treat a wide range of bacterial infections. Amoxycillin, a beta-lactam antibiotic, acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. Clavulanic Acid, a beta-lactamase inhibitor, enhances the efficacy of Amoxycillin by preventing the degradation of the antibiotic by beta-lactamase enzymes produced by resistant bacteria. This synergistic action broadens the antimicrobial spectrum, making Kurepen-XL effective against beta-lactamase producing strains of bacteria. It is commonly prescribed for respiratory tract infections such as sinusitis, bronchitis, and pneumonia, as well as urinary tract infections, skin and soft tissue infections, and dental infections. The extended-release formulation ensures sustained plasma concentrations, allowing for convenient twice-daily dosing. Kurepen-XL should be used under medical supervision, with dosage adjustments based on infection severity and patient renal function. Common side effects may include gastrointestinal disturbances such as nausea, diarrhea, and abdominal discomfort. Hypersensitivity reactions are rare but warrant immediate medical attention. This medication is contraindicated in patients with a history of penicillin allergy or severe hepatic impairment. Proper adherence to prescribed therapy is essential to prevent antibiotic resistance and ensure optimal clinical outcomes.